- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06517459
Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino
Study Overview
Detailed Description
Weight gain greatly increases the risk of chronic diseases such as diabetes, metabolic syndrome, pulmonary and heart disease. The Group Lifestyle Balance (GLB) intervention is a 12-month, evidence-based weight-loss program that has been used extensively with the general population and with people after CVA, however, it is not adapted to be linguistically and culturally appropriate for Latino persons post stroke. We will modified the program to meet the needs of Latino people with a CVA (GLB-CVA Latino).
Aims:
- : To create a modification of the CDC-recognized, evidence-based GLB-CVA to be culturally appropriate to meet the unique needs of people who identify as Hispanic/Latino, available in English and Spanish languages, using a Community-Based Participatory Research approach and AB of key stakeholders (patients, caregivers, clinicians, researchers).
- : Conduct a single-arm trial to describe the effect of participation in the GLB-CVA Latino on primary and secondary outcomes for 24 individuals who identify as Hispanic/Latino (12 English speakers and 12 Spanish speakers) at 3, 6, and 12 months from baseline.
- : Evaluate the participant compliance (feasibility) and fidelity (adherence to the DPP GLB content) with the GLB-CVA Latino intervention.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alvaro Carrera
- Phone Number: 469-831-5321
- Email: alvaro.carrera@bswhealth.org
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75246
- Recruiting
- Baylor Institute for Rehabilitation
-
Contact:
- Alvaro Carrera
- Phone Number: 4698315321
- Email: alvaro.carrera@bswhealth.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- BMI ≥25
- Identify as Hispanic or Latino
- 18-85 years of age
- All types of stroke
- Medically able to participate in a weight-loss program
- Physical Activity Readiness Questionnaire +
- ≥12 months post first stroke
Exclusion Criteria:
- Contraindications for physical activity
- Low Cognitive Function
- Residing in hospital, acute rehab, SNF
- Not fluent in English or Spanish
- Pre-existing eating disorder
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: GLB CVA Latino
The GLB program, adapted for Latino individuals with stroke, will be delivered to participants over a 12-month period, divided into 22 in-person or virtual, group sessions. The goal of the GLB program is to help the participant achieve and maintain a 5-7% weight-loss using a two-pronged approach:
|
The Group Lifestyle Balance (GLB) program is a self-management intervention that has been shown to result in weight-loss and reduce the risk for Type 2 diabetes through increased physical activity and healthy eating behaviors in the general population.
The GLB is a direct adaptation of the Diabetes Prevention Program, both developed at the Diabetes Prevention and Support Center at the University of Pittsburgh.
The GLB is designed for delivery in a group-based, community setting,4 and has resulted in weight-loss in a variety of settings, such as community centers, churches, worksites, and healthcare systems.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in weight
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Weight will be measured during in-person assessments at BSWIR using a Seca 664 scale.
Height will be measured using a stadiometer.
Weight and height will be used to calculate BMI.
A BodyTrace Smart Scale will be provided to participants to facilitate self-weighing in the home, which include cellular connectivity at no cost to participants so weight will be sent directly to the research team.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Circumference
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Waist circumference measured at the umbilicus and mid-upper arm circumference following ACSM guidelines.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Height
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Will be collected using a stadiometer and used to calculate BMI
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Blood pressure
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Using an automatic cuff (average of three readings, patient seated) diastolic and systolic scores will be recorded
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
8-year Diabetes Risk
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
The Framingham Heart Study diabetes risk score83 will be calculated using predictors including age, gender, fasting glucose, BMI, HDL cholesterol and triglyceride levels, blood pressure, and parental history.
Risk score calculator and regression model are free and used in GLB weight-loss trials.
The age range for this score is 45 years to 64 years, and therefore only individuals within this age will have calculated scores.
Furthermore, the minimum cut-off score is 3.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
6 Minute Walk Test (6MWT)
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
10 Meter Walk Test (10MWT)
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Assesses walking speed in (m/s) which is correlated to mobility in the community, capacity to perform ADLs, risk of falls, re-hospitalization, and risk of cognitive decline.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Behavioral Risk Factor Surveillance System (BRFSS)
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
The BRFSS is a state-based system of health surveys that collects information on health risk behaviors, preventative health practices, and health care access primarily related to chronic disease and injury.
The GLB-TBI uses the two subscales of Healthy Eating and Physical Activity from the 2017 version of the BRFSS.
It consists of 14 items.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Neighborhood Environment Walkability Scale (NEWS)
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
NEWS assesses participants' perception of neighborhood features related to physical activity and grocery shopping, including residential density, land use mix (including both indices of proximity and accessibility), street connectivity, infrastructure for walking/cycling, neighborhood aesthetics, traffic and crime safety, and neighborhood satisfaction.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Short Assessment of Health Literacy
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Combined word recognition test and comprehension test using multiple-choice questions.
Identifies individuals with low health literacy.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Self-Rated Abilities for Health Practice
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Includes 28 items to assess health behaviors among people with disabilities and yields a total Health Practices Score plus 4 subscale scores (Exercise, Nutrition, Health Practices, and Psychological Well Being).
Items are rated on a 5-point scale from 0 'not at all' to 4 'completely.'
Scores range from 0-28 with higher scores indicating higher self-efficacy for the health behaviors.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Stroke Impact Scale - Quality of Life
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Quality of life will be assessed using the Stroke Impact Scale, which assesses 8 dimensions of health-related quality of life specific to people post stroke including subscales (using a 5pt Likert scale) assessing strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Change in Exit Survey
Time Frame: [Time Frame: 12 months]
|
Participants will be asked to complete an exit survey at the 12-month assessment, asking about experience in, and satisfaction with, the GLB-CVA Latino (including satisfaction and feasibility with modifications and language translation) and suggestions for improvement.
|
[Time Frame: 12 months]
|
|
Brief Acculturation Scale for Hispanics
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
4 item language based measure of acculturation for Hispanic populations.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Social Support for Eating Habits
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Questionnaire that assesses the frequency of support received from others for healthy eating habits over the past 3 months.
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Social Support for Physical Activity
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Questionnaire that assesses the frequency of support received from others for engaging in physical activity over the past 3 months
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
HbA1c
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Fasting venous sample will be obtained for hemoglobin a1c to assess average blood sugar level over the past 2-3 months.
Fasting venous samples will also be collected for fasting blood glucose, HDL/LDL, total cholesterol, and triglyceride level.
Coordinators are trained phlebotomists
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Fasting blood glucose
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Fasting venous sample will be obtained for hemoglobin a1c to assess average blood sugar level over the past 2-3 months.
Fasting venous samples will also be collected for fasting blood glucose, HDL/LDL, total cholesterol, and triglyceride level.
Coordinators are trained phlebotomists
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
|
Lipid panel
Time Frame: [Time Frame: Baseline, 3, 6, and 12 months]
|
Fasting venous sample will be obtained for hemoglobin a1c to assess average blood sugar level over the past 2-3 months.
Fasting venous samples will also be collected for fasting blood glucose, HDL/LDL, total cholesterol, and triglyceride level.
Coordinators are trained phlebotomists
|
[Time Frame: Baseline, 3, 6, and 12 months]
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Librada Callender, PhD, MPH, Baylor Scott and White Research Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 024-268
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
Clinical Trials on Group Lifestyle Balance
-
Ohio State UniversityCompleted
-
Universidad de SonoraUnknown
-
Baylor Research InstituteNational Institute on Disability, Independent Living, and Rehabilitation...Active, not recruiting
-
Baylor Research InstituteUniversity of Texas Southwestern Medical Center; National Institute on Disability...Active, not recruitingTraumatic Brain InjuryUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Cardiovascular Risk Factor | Diabetes Mellitus Risk
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Completed
-
University of Illinois at Urbana-ChampaignCompletedPhysical Activity | Self Efficacy | Working AdultsUnited States
-
David Grant U.S. Air Force Medical CenterCompletedPrimary Prevention
-
University of ArkansasCompletedOverweight | Memory Disorder
-
VA Office of Research and DevelopmentCompletedObesity | Diabetes | Weight GainUnited States